Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-18T09:11:31.506Z Has data issue: false hasContentIssue false

Autism and MMR Vaccination or Thimerosal Exposure: An Urban Legend?

Published online by Cambridge University Press:  02 December 2014

Michael Shevell
Affiliation:
Montreal, Quebec, Canada
Eric Fombonne
Affiliation:
Montreal, Quebec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2006

References

2. Wakefield, AJ, March, SH, Anthony, A, Linnell, J, Casson, DM, Malik, M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:63741.Google Scholar
3. Murch, SH, Anthony, A, Casson, DH, Malik, M, Berelowitz, M, Dhillon, AP, et al. Retraction of an interpretation. Lancet. 2004;363:750.Google Scholar
4. Halsey, N, Hyman, S. Conference Writing Panel. Measles, mumps and rubella vaccine and Autism spectrum disorder. Report from the New Challenges in Childhood Immunization Conference convened at Oak Brook, Illinois, June 12-13, 2001 . Pediatrics. 2001;107:123.Google Scholar
5. Bernard, S, Enayati, A, Redwood, L, Roger, H, Binstock, T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56:46271.CrossRefGoogle ScholarPubMed
6. Doja, A, Roberts, W. Immunizations & autism: a review of the literature. Can J Neurol Sci. 2006;33:341346.Google Scholar
7. Madsen, KM, Hviid, A, Vestergaard, M, Schendel, D, Wohlfahrt, J, Thorsen, P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. NEJM. 2002;347:147782.CrossRefGoogle ScholarPubMed
8. Taylor, B, Miller, E, Farrington, CP, Petropoulos, MC, Faust-Mayaud, I, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:20269.Google Scholar
9. Chen, W, Landau, S, Sham, P, Fombonne, E. No evidence for links between autism, MMR and measles virus. Psychol Med. 2004;34:54353.Google Scholar
10. Smeeth, L, Cook, C, Fombonne, E, Heavey, L, Rodrigues, LC, Smith, PG, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004;364:9639.CrossRefGoogle ScholarPubMed
11. Makela, A, Nuorti, JP, Petola, H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002;110:95763.Google Scholar
12. Gillberg, C, Heijbel, H. MMR and autism. Autism. 1998;2:4234.Google Scholar
13. Dales, L, Hammer, SJ, Smith, NJ. Time trends in autism and MMR immunization coverage in California. JAMA. 2001;286:11835.Google Scholar
14. Honda, H, Shimizu, Y, Rutter, M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry. 2005;46:5729.Google Scholar
15. Fombonne, E, Zakarian, R, Bennett, A, Meng, L, McLean-Heywood, D. Pervasive developmental disorders in Montreal, Quebec, Canada. Prevalence and links with immunizations. Pediatrics. 2006;118:e13950.Google Scholar
16. Institute of Medicine. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academies Press; 2004.Google Scholar
17. Smeeth, L, Rodrigues, LC, Hall, AJ, Fombonne, E, Smith, PG. Evaluation of adverse effects of vaccines: the case-control approach. Vaccine. 2002;20:26117.CrossRefGoogle ScholarPubMed
18. Fombonne, E. Autism & immunization. In: Encyclopedia on early childhood development. Montreal, 2006. p.18.Google Scholar
19. Afzal, MA, Ozoemena, LC, O’Hare, A, Kidger, KA, Bentley, ML, Minor, PD. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol. 2006;78:62330.Google Scholar
20. D’Scouza, Y, Ward, B, Fombonne, E. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics. (In Press).Google Scholar
21. Andrews, N, Miller, E, Grant, A, Stowe, J, Osborne, V, Taylor, B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;114:58491.Google Scholar
22. Heron, J, Golding, J. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;57783.Google Scholar
23. Hviid, A, Stellfeld, M, Wohlfahrt, J, Melbye, M. Association between thimerosal-containing vaccine and autism. JAMA. 2003;290: 17636.Google Scholar
24. Verstraeten, T, Davis, RL, DeStefano, F, Lieu, TA, Rhodes, PH, Black, SB, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112:103948.Google Scholar
25. Madsen, KM, Lauritsen, MB, Pedersen, CB, Thorsen, PB, Plesner, AM, Andersen, PH, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003;112:6046.CrossRefGoogle ScholarPubMed
26. Stehr-Green, P, Tull, P, Stellfeld, M, Mortenson, PB, Simpson, D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. AM J Prev Med. 2003;25:1016.Google Scholar
27. Parker, SK, Schwartz, B, Todd, J, Pickering, LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004;114:793804.CrossRefGoogle ScholarPubMed
28. Ip, P, Wong, V, Ho, M, Lee, J, Wong, W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004;19:4314.Google Scholar
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington D.C.: American Psychiatric Association; 1994.Google Scholar
30. Filipek, PA, Accardo, PA, Baranek, GT, Cook, EH Jr, Dawson, G, Gordon, B, et al. The screening and diagnosis of autistic spectrum disorders. J Aut Dev Dis. 1999;29:43984.Google Scholar
31. Shevell, MI, Majnemer, A, Rosenbaum, P, Abrahamowicz, M. Etiologic yield of autistic spectrum disorders: a prospective study. J Child Neurol. 2001;16:50912.Google Scholar
32. Hiotz, DG, Wojnr, A, Filipek, PA. Autistic spectrum disorders. In: Swaiman, K, Ashwal, S, Ferreir, M, editors. Pediatric Neurology: Principle and Practice (4th Ed). Philadelphia: Mosby Elsevier; 2006. p. 905936.Google Scholar
33. Salmon, DA, Haber, M, Gangarosa, EJ, Phillips, L, Smith, NJ, Chen, RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999;282:4753.Google Scholar
34. Griffin, MR, Ray, WA, Mortimer, EA, Fenichel, GM, Schaffer, W. Risk of seizures and encephalopathy after immunizations with the diphtheria-tetanus-pertussis vaccine. JAMA. 1990;263:164045.Google Scholar
35. Jansen, VA, Stollenwerk, N, Jensen, HJ, Ramsay, ME, Edmunds, WJ, Rhodes, CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 2003;301:804.Google Scholar
36. Shannon, M, Levy, S, Sandler, A. Chelation therapy neither safe nor effective as autism treatment. AAP news 2001:63.Google Scholar
37. Muhle, R, Trentacose, SV, Rapin, I. The genetics of autism. Pediatrics 2004;113. Available from: www.pediatrics.org/cgi/content/full/113/5/e472.Google Scholar
38. Helsat, MR, Caviness, VS. Jr Neuroanatomy and imaging studies. In: Autism: a neurological disorder of early brain development. London: Mckneill Press; 2006. p.11540.Google Scholar